BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18753653)

  • 21. Preterm labor: approach to decreasing complications of prematurity.
    Locatelli A; Consonni S; Ghidini A
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Usta IM; Nassar AH
    Am J Obstet Gynecol; 2003 Aug; 189(2):614-5; author reply 615-6. PubMed ID: 14524364
    [No Abstract]   [Full Text] [Related]  

  • 23. Magnesium sulfate for cerebral palsy prevention.
    Rouse DJ; Gibbins KJ
    Semin Perinatol; 2013 Dec; 37(6):414-6. PubMed ID: 24290398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
    Crowther CA; Hiller JE; Doyle LW; Haslam RR;
    JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
    N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
    Borna S; Saeidi FM
    J Obstet Gynaecol Res; 2007 Oct; 33(5):631-4. PubMed ID: 17845320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnesium sulfate: the first-line tocolytic.
    Lewis DF
    Obstet Gynecol Clin North Am; 2005 Sep; 32(3):485-500. PubMed ID: 16125045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Dambrosia J; Pryde PG; Lee KS; Gianopoulos JG; Besinger RE; Tomich PG
    Am J Obstet Gynecol; 2002 Jun; 186(6):1111-8. PubMed ID: 12066082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Rouse DJ; Hirtz DG; Thom E
    Am J Obstet Gynecol; 2003 Jan; 188(1):295. PubMed ID: 12548234
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    McElrath TF
    Am J Obstet Gynecol; 2003 Jan; 188(1):294; author reply 294-5. PubMed ID: 12548232
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
    Marret S; Chollat C; Levèque C; Marpeau L
    Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ
    Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More on prenatal magnesium sulfate and risk of cerebral palsy.
    Nelson KB; Grether JK
    JAMA; 1997 Nov; 278(18):1493. PubMed ID: 9363965
    [No Abstract]   [Full Text] [Related]  

  • 35. Developments in the pharmacotherapeutic management of spontaneous preterm labor.
    Kam KY; Lamont RF
    Expert Opin Pharmacother; 2008 May; 9(7):1153-68. PubMed ID: 18422473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The control of labor.
    Pryde PG; Mittendorf R
    N Engl J Med; 1999 Dec; 341(27):2098-9. PubMed ID: 10627205
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnesium and the obstetric anaesthetist.
    Dean C; Douglas J
    Int J Obstet Anesth; 2013 Jan; 22(1):52-63. PubMed ID: 23182610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium sulfate tocolysis: time to quit.
    Grimes DA; Nanda K
    Obstet Gynecol; 2006 Oct; 108(4):986-9. PubMed ID: 17012463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What gestation cut-off should be used for magnesium sulfate treatment of women threatening to deliver preterm?
    Knight DB; Gardener GJ
    Am J Obstet Gynecol; 2010 Mar; 202(3):e9; author reply e9-10. PubMed ID: 19889392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.